ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

EVAX Evaxion Biotech AS

2.67
0.20 (8.10%)
Jun 18 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Evaxion Biotech AS EVAX NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.20 8.10% 2.67 15:30:00
Open Price Low Price High Price Close Price Previous Close
2.58 2.58 2.83 2.67 2.47
more quote information »

Recent News

Date Time Source Heading
6/18/202415:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/17/202408:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/17/202407:44GLOBEEvaxion Publishes Data, Showing 67% Objective Response Rate..
6/07/202416:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/03/202408:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/03/202407:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/03/202407:00GLOBEEvaxion Presents Positive and Validating Immune Data from..
5/28/202408:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/28/202407:21GLOBEEvaxion Announces Business Update and First Quarter 2024..
5/24/202415:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/23/202416:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/23/202416:00GLOBEEvaxion to Present New Positive Data from Ongoing Phase 2..
5/10/202416:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/10/202416:00GLOBEEvaxion Receives Nasdaq Notification
5/06/202416:01EDGAR2Form F-1 - Registration statement for certain foreign..
4/17/202407:00GLOBEEvaxion Announces Phase 2 Clinical Trial Update: First..
4/02/202406:00GLOBEEvaxion and Undisclosed Collaborator Announce Encouraging..
3/27/202406:30GLOBEEvaxion Announces Business Update and Full Year 2023..
3/19/202406:30GLOBEEvaxion Hosts R&D Day and Unveils the Broad Potential of Its..
2/29/202406:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/29/202406:30GLOBEEvaxion to Host R&D Day on March 19, 2024, Highlighting its..
2/20/202406:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/20/202406:30GLOBEEvaxion Announces Successful Completion of the Initial..
2/07/202415:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/07/202407:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/07/202407:30GLOBEEvaxion Regains Compliance with Nasdaq Minimum Bid Price..
2/06/202407:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/06/202407:30GLOBEEvaxion Announces Closing of $15 Million Public Offering
2/05/202408:09EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2/05/202406:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/01/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
2/01/202408:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/01/202408:20GLOBEEvaxion Biotech Announces Pricing of $15 Million Public..
1/31/202416:10EDGAR2Form F-1/A - Registration statement for certain foreign..
1/31/202408:26EDGAR2Form F-1/A - Registration statement for certain foreign..
1/30/202414:16EDGAR2Form F-1/A - Registration statement for certain foreign..
1/26/202415:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/24/202413:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/24/202407:30GLOBEEvaxion to Develop Tailored Novel Cancer Vaccines Based upon..
1/22/202415:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/22/202415:30GLOBEEvaxion Announces Completion of ADS Ratio Change
1/12/202416:17EDGAR2Form F-1 - Registration statement for certain foreign..
1/12/202408:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/10/202407:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/08/202407:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/08/202407:30GLOBEEvaxion Announces Plan to Implement ADS Ratio Change
12/21/202315:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/21/202315:30GLOBEEvaxion Biotech Announces Closing of Private Placement
12/19/202315:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/19/202315:15GLOBEEvaxion Announces Business Update and Third Quarter 2023..